Estrogen replacement increases matrix metalloproteinase contribution to vasoconstriction in a rat model of menopause

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Hypertension

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/HJH.0b013e32832c41b5PMID 19412129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

  2008cited by this paper
• Estrogen is a modulator of vascular inflammation

  2008cited by this paper
• Endothelin-1, aging and hypertension

  2008cited by this paper
• The molecular mechanisms of the thrombotic complications of atherosclerosis

  2008cited by this paper
• Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches.

  2007cited by this paper
• Estrogen therapy and coronary-artery calcification.

  2007cited by this paper
• Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia.

  2007cited by this paper
• A critique of Women’s Health Initiative Studies (2002-2006)

  2006cited by this paper
• Tumor Necrosis Factor-&agr; and Vascular Angiotensin II in Estrogen-Deficient Rats

  2006cited by this paper
• Cardiovascular disease, estrogen deficiency, and inflammatory cytokines.

  2006cited by this paper
• Enzymatic pathways involved in the generation of endothelin‐1(1–31) from exogenous big endothelin‐1 in the rabbit aorta

  2006cited by this paper
• Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-&bgr;1 (TGF-&bgr;1) and TGF-&bgr;1–Type II Receptor Signaling Within the Aged Arterial Wall

  2006cited by this paper
• Chronic Tumor Necrosis Factor-&agr; Inhibition Enhances NO Modulation of Vascular Function in Estrogen-Deficient Rats

  2005cited by this paper
• Cytokines and vascular reactivity in resistance arteries.

  2005cited by this paper
• Inflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity

  2005cited by this paper
• Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade

  2005cited by this paper
• Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator.

  2004cited by this paper
• Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha.

  2004cited by this paper
• Novel mechanisms responsible for postmenopausal hypertension.

  2004cited by this paper
• Regulation of Matrix Metalloproteinases by Cytokines and Reactive Oxygen/Nitrogen Species in the Myocardium

  2004cited by this paper
• Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction

  2004cited by this paper
• Aging‐induced proinflammatory shift in cytokine expression profile in rat coronary arteries

  2003cited by this paper
• The protective effects of estrogen on the cardiovascular system.

  2002cited by this paper
• Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2.

  2002cited by this paper
• Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In Vitro

  2000cited by this paper
• Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro.

  2000cited by this paper
• Estrogen Replacement Reduces Age-Associated Remodeling in Rat Mesenteric Arteries

  2000cited by this paper
• Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction

  2000cited by this paper
• Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor.

  1999cited by this paper
• 17β-Oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells

  1998cited by this paper
• 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells.

  1998cited by this paper
• Vascular Biology, Atherosclerosis and Endothelium Biology Vasculoprotective Effects of Anti-Tumor Necrosis Factor- (cid:1) Treatment in Aging

  year unknowncited by this paper

• Aberrant Uteroplacental and Vascular Signaling and Remodeling by Matrix Metalloproteinases in Pregnancy-Related Hypertension and Preeclampsia

  2026cites this paper
• Ovariectomy drives increase of an ECM transcription signature in the posterior eye and retina.

  2024cites this paper
• Urinary phenol and paraben concentrations in association with markers of inflammation during pregnancy in Puerto Rico.

  2024cites this paper
• The effects of female sexual hormones on the endothelial glycocalyx.

  2023cites this paper
• Advanced Maternal Age Impairs Uterine Artery Adaptations to Pregnancy in Rats

  2022cites this paper
• Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine

  2021cites this paper
• Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis

  2020cites this paper
• The Impact Of Exercise On Inflammation, Oxidative Stress And Remodelling In Cardiac Muscle

  2020cites this paper
• Estrogen-induced FOS-like 1 regulates matrix metalloproteinase expression and the motility of human endometrial and decidual stromal cells

  2020cites this paper
• Is the Expression of the Components of the Carotid Matrix of Rats Influenced by Estrogen, Progestin and Tibolone?

  2019cites this paper
• Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

  2017cites this paper
• Knowledge-transfer learning for prediction of matrix metalloprotease substrate-cleavage sites

  2017cites this paper
• Assessing Direct Vascular Actions of Estrogens.

  2016cites this paper
• Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation.

  2015cites this paper
• Therapeutic Implications of Estrogen for Cerebral Vasospasm and Delayed Cerebral Ischemia Induced by Aneurysmal Subarachnoid Hemorrhage

  2014cites this paper
• Prenatal Hypoxia Causes Long-Term Alterations in Vascular Endothelin-1 Function in Aged Male, but Not Female, Offspring

  2013cites this paper
• EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.

  2013cites this paper
• Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case–control study in the Multiethnic Cohort study

  2012cites this paper
• Increased MMPs expression and decreased contraction in the rat myometrium during pregnancy and in response to prolonged stretch and sex hormones.

  2012cites this paper
• Altered neuronal nitric oxide synthase in the aging vascular system: implications for estrogens therapy.

  2012cites this paper
• Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

  2012cites this paper
• The role of cytokines in cardiovascular disease in menopause

  2012cites this paper
• Effects of Diosgenin on Myometrial Matrix Metalloproteinase-2 and -9 Activity and Expression in Ovariectomized Rats

  2011cites this paper
• ET-11 APS International Conference on Endothelin Endothelin in the female vasculature : a role in aging ?

  2010cites this paper
• Ovariectomy in aged versus young rats augments matrix metalloproteinase-mediated vasoconstriction in mesenteric arteries

  2010cites this paper